# IGC BIO INC. — Form D/A

IGC BIO INC. of BOSTON, MA, a company, filed a Form D amendment with the SEC on 2018-07-24. The offering totals $2.2M, of which $2.2M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2018-07-24
- Form: D/A
- Accession: 0001668051-18-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.2M
- Amount sold: $2.2M
- Investors: 1
- Date of first sale: 2017-10-27
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-298608

## Issuer

- Name: IGC BIO INC.
- CIK: 0001668051
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 50 CONGRESS STREET, BOSTON, MA, 02109
- Phone: 617-228-5720

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Joseph Jacobson | Director | San Jose, CA |
| Oded Kadosh | Director | BOSTON, MA |
| Jeremy Wertheimer | Director | CAMBRIDGE, MA |
| Tamar Erdfarb | Director | CAMBRIDGE, MA |

## Other filings by this issuer (3)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2018-07-24](https://search.stillhousedata.com/formd/0001668051-18-000001) | D/A | $1.6M | $1.6M |
| [2017-11-13](https://search.stillhousedata.com/formd/0001668051-17-000001) | D | $1.5M | $1.5M |
| [2016-10-14](https://search.stillhousedata.com/formd/0001668051-16-000002) | D | $2.5M | $2.5M |

## More

- [CIK 1668051 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1668051&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001668051-18-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.